
<DOC>
<DOCNO>
WSJ900725-0157
</DOCNO>
<DOCID>
900725-0157.
</DOCID>
<HL>
   Who's News:
   Synergen Inc.
</HL>
<DATE>
07/25/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE B6
</SO>
<CO>
   SYGN WNEWS
</CO>
<LP>
   SYNERGEN Inc. (Boulder. Colo.) -- Arthur Hull Hayes Jr.
was elected a director of this biotechnology company,
increasing the board's size to eight. Dr. Hayes is president
and chief executive officer of EM Pharmaceuticals Inc. and a
professor of medicine at New York Medical College.
</LP>
<TEXT>
</TEXT>
</DOC>